Gillies, G.E. and McArthur, S. 2010. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacological reviews. 62 (2), pp. 155-198. https://doi.org/10.1124/pr.109.002071
| Title | Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines |
|---|---|
| Authors | Gillies, G.E. and McArthur, S. |
| Abstract | The classic view of estrogen actions in the brain was confined to regulation of ovulation and reproductive behavior in the female of all mammalian species studied, including humans. Burgeoning evidence now documents profound effects of estrogens on learning, memory, and mood as well as neurodevelopmental and neurodegenerative processes. Most data derive from studies in females, but there is mounting recognition that estrogens play important roles in the male brain, where they can be generated from circulating testosterone by local aromatase enzymes or synthesized de novo by neurons and glia. Estrogen-based therapy therefore holds considerable promise for brain disorders that affect both men and women. However, as investigations are beginning to consider the role of estrogens in the male brain more carefully, it emerges that they have different, even opposite, effects as well as similar effects in male and female brains. This review focuses on these differences, including sex dimorphisms in the ability of estradiol to influence synaptic plasticity, neurotransmission, neurodegeneration, and cognition, which, we argue, are due in a large part to sex differences in the organization of the underlying circuitry. There are notable sex differences in the incidence and manifestations of virtually all central nervous system disorders, including neurodegenerative disease (Parkinson's and Alzheimer's), drug abuse, anxiety, and depression. Understanding the cellular and molecular basis of sex differences in brain physiology and responses to estrogen and estrogen mimics is, therefore, vitally important for understanding the nature and origins of sex-specific pathological conditions and for designing novel hormone-based therapeutic agents that will have optimal effectiveness in men or women. |
| Journal | Pharmacological reviews |
| Journal citation | 62 (2), pp. 155-198 |
| ISSN | 1521-0081 |
| Year | Jun 2010 |
| Publisher | American Society for Pharmacology and Experimental Therapeutics |
| Digital Object Identifier (DOI) | https://doi.org/10.1124/pr.109.002071 |
| Publication dates | |
| Published | Jun 2010 |